ProsCan: Prostate cancer supportive care and patient outcomes project
- Conditions
- Prostate cancerPatterns of carePsychosocial and physical functioning outcomesGeneticsTreatment-decison makingEconomic EvaluationCancer - Prostate
- Registration Number
- ACTRN12607000233426
- Lead Sponsor
- The Cancer Council Queensland
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Male
- Target Recruitment
- 1000
First histological diagnosis of prostate cancer of any stage
Diagnosed in Queensland
Ability to give informed consent
English-speaking
Access to telephone.
Additional inclusion criteria for the intervention component of the ProsCan project: Diagnosis of localised prostate cancer
Cognitive impairment.
Additional exclusion criteria for the intervention component of the ProsCan project: Locally advanced or metastatic prostate cancer Psychiatric illness Receiving active treatment for another cancer
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Efficacy of a telephone-based Support Intervention through improved psychosocial and physical functioning using the following measures: Decisional Conflict Scale; Decisional Regret Scale; Happiness Scale; Constructed Meaning Scale; Brief Distress Thermometer; Revised Impact of Events Scale; Short Form -36 (SF36 - Registered Trademark); Life Orientation Scale; International Prostate Symptom Score; Expanded Prostate Cancer Index Composite; Enhancing Recovery in Coronary Heart Disease (ENRICHD) Social Support Instrument; Satisfaction with Life Scale.[Baseline, 2, 6, 12, 24, 36, 48 and 60 months post-treatment.]
- Secondary Outcome Measures
Name Time Method